Dementia Alzheimers
61
8
14
30
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.6%
1 terminated out of 61 trials
96.8%
+10.3% vs benchmark
2%
1 trials in Phase 3/4
30%
9 of 30 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 30 completed trials
Clinical Trials (61)
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Assessing Cognitive Decline at Home
The Nightlight Falls Prevention Study
MASC: Reducing Stress for Caregivers
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Palliative Care for Persons With Late-stage Alzheimer's and Related Dementias and Their Caregivers
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Care Coordination System for People With Dementia
Person-Environment Fit for Persons With Dementia
Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury
Persons With Dementia and Their Extended Family Caregivers
The Care Ecosystem Consortium Effectiveness Study
A Spanish-language Caregiver-Enabled Care Program
Rural Dementia Caregiver Project
HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population
Acrylamide and Health Outcomes
Monitoring Anti-Dementia Drugs by Serum Levels
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE)